SV
Sophie V. Vandebroek
Director

Sophie V. Vandebroek insider trades: Idexx Laboratories (IDXX) stock buys and sales

Director, Idexx Laboratories Last trade Feb 17, 2026 51 Form 4 filings
$920K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2012
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Sophie reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 17, 2026IDXX↓ Sell$920K
May 9, 2025IDXX↓ Sell$628K
Nov 27, 2024IDXX↓ Sell$145K
Mar 5, 2024IDXX↓ Sell$790K
May 4, 2023IDXX↓ Sell$1.0M
Feb 12, 2021IDXX↓ Sell$1.6M
Feb 18, 2020IDXX↓ Sell$2.2M
Aug 5, 2019IDXX↓ Sell$2.4M
Aug 3, 2018IDXX↓ Sell$786K
Nov 22, 2013IDXX↑ Buy$108K
Mar 9, 2012ALOG↓ Sell$128K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other IDXX insiders

Open-market trades in the last 12 months

About Sophie V. Vandebroek's insider trades

Sophie V. Vandebroek is a director at Idexx Laboratories (IDXX). Since Mar 9, 2012, Sophie has reported 1 open-market purchase worth $108K and 10 sales worth $10.6M on SEC Form 4. In the last 12 months: 1 sale ($920K).

Their filings also include grants and awards (36 filings), option exercises (14 filings), gifts (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IDXX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.